Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

48 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Eligibility NCT00655252 Metastatic Renal Cell Cancer - Eligibility

- 09-12-13 - 1 Formulier, 2 Itemgroepen, 10 Data-elementen, 2 Talen
Itemgroepen: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00655252

Kidney Cancer NCT01198158 Registration - CALGB 90802 Registration Worksheet Form - 3103555v1.0 - CALGB 90802 Registration Worksheet Form

- 20-09-21 - 1 Formulier, 10 Itemgroepen, 44 Data-elementen, 1 Taal
Itemgroepen: Header Module, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Patient Demographics/Pre-Treatment Characteristics2, Patient Demographics/Pre-Treatment Characteristics3, Certification Of Eligibility, Protocol Design, Initial Patient Consent For Specimen Use, CALGB 580902, Registration Information
CALGB 90802 Registration Worksheet Form Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=879626AD-DB8C-4AF2-E040-BB89AD4364E1

E2805 Renal Cell Carcinoma On-Study Form NCT00326898

- 20-09-21 - 1 Formulier, 9 Itemgroepen, 50 Data-elementen, 1 Taal
Itemgroepen: Header, Data amendment, Patient demographics, History of Disease, Description of Primary Disease, Description of Current Disease, Current Disease Symptoms, MUGA Scanning, Footer Module
E2805 Renal Cell Carcinoma On-Study Form NCT00326898 Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=053ADDEA-1681-66BC-E044-0003BA3F9857

Kidney Cancer NCT01120249 Response - Southwest Oncology Group S0931 Recurrence Assessment Form (Form #46940) - 2998562v1.0 - Southwest Oncology Group S0931 Recurrence Assessment Form (Form #46940)

- 20-09-21 - 1 Formulier, 4 Itemgroepen, 24 Data-elementen, 1 Taal
Itemgroepen: Header Module, Clinical Assessment, Notice of Recurrence, COMMENTS
Southwest Oncology Group S0931 Recurrence Assessment Form (Form #46940) Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7E26385C-8CD8-C34F-E040-BB89AD434A8D

E2805 Material Submission Form NCT00326898

- 20-09-21 - 1 Formulier, 6 Itemgroepen, 31 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, Biopsy specimen / Lab, Completed by Central Lab, Contacts, Comments
E2805 Material Submission Form NCT00326898 Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=05B6F9C4-7323-1449-E044-0003BA3F9857

Kidney Cancer NCT00326898 Treatment - E2805 Concomitant Medication Form - 2444090v1.0 - E2805 Concomitant Medication Form

- 14-07-17 - 1 Formulier, 3 Itemgroepen, 34 Data-elementen, 1 Taal
Itemgroepen: Administrative documentation, Concomitant medication, Comments
E2805 Concomitant Medication Form Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0B593E1B-ACB3-37BB-E044-0003BA3F9857

E2805 Adverse Event Form - (CTCAE v3) NCT00326898

- 08-07-15 - 1 Formulier, 11 Itemgroepen, 51 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, Data amendment, ON TREATMENT, OFF TREATMENT, Adverse Event Current Assessment, BLOOD/BONE MARROW/METABOLIC - LABS, NON-HEMATOLOGIC, II. INFECTIONS, Other Adverse Events, Comments
E2805 Adverse Event Form - (CTCAE v3) NCT00326898 Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0538F350-3C05-47A5-E044-0003BA3F9857

E2805 Surgery Form NCT00326898

- 16-06-15 - 1 Formulier, 8 Itemgroepen, 48 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, Data amendment, Section I - Surgery and Staging, Pathologic Tumor Staging, Section II - Surgical Complications, Section III - Lymph Node Dissection, Footer
E2805 Surgery Form NCT00326898 Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=053C633F-4176-6FE5-E044-0003BA3F9857

E2805 Second Primary Form NCT00326898

- 16-06-15 - 1 Formulier, 4 Itemgroepen, 18 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, Second primary cancer assessment, Footer module
E2805 Second Primary Form NCT00326898 Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=054BADA9-3263-36C2-E044-0003BA3F9857

E2805 Non-Protocol Therapy Form NCT00326898

- 16-06-15 - 1 Formulier, 4 Itemgroepen, 25 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, Off-protocol treatment, Comments
E2805 Non-Protocol Therapy Form NCT00326898 Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=054A9BCE-D49E-2448-E044-0003BA3F9857

E2805 Treatment Form NCT00326898

- 08-06-15 - 1 Formulier, 12 Itemgroepen, 65 Data-elementen, 1 Taal
Itemgroepen: Header, Patient demographics, Data amendment, Section I - Vital Status, Section II - Patient Characteristics, Section III - Therapy Administered, Dose Modifications, Assessment of medication, Dose Modifications, Section IV - Blood Pressure, MUGA Scanning, Section VI - Non-Protocol Therapy
E2805 Treatment Form NCT00326898 Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=054B80EC-08C8-3374-E044-0003BA3F9857

Kidney Cancer NCT01198158 Toxicity - CALGB 90802 Adverse Event (AE) Form - 3103307v1.0 - CALGB 90802 Adverse Event (AE) Form

- 09-01-15 - 1 Formulier, 4 Itemgroepen, 23 Data-elementen, 1 Taal
Itemgroepen: Header Module, Header, AdEERS Information, Solicited Adverse Events
CALGB 90802 Adverse Event (AE) Form Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=87856A36-E968-CA3E-E040-BB89AD431C27

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial